Merck & Co., Inc.MRKNYSE
Loading
EBITDA Margin Over TimeStrong
Percentile Rank86
3Y CAGR+2.8%
5Y CAGR+9.7%
Year-over-Year Change
EBITDA as a percentage of revenue
3Y CAGR
+2.8%/yr
vs +2.1%/yr prior
5Y CAGR
+9.7%/yr
Recent deceleration
Acceleration
+0.7pp
Accelerating
Percentile
P86
Within normal range
vs 5Y Ago
1.6x
Solid growth
Streak
1 yr
Consecutive declineStrong
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 39.01% | -2.6% |
| 2024 | 40.06% | +248.7% |
| 2023 | 11.49% | -68.0% |
| 2022 | 35.95% | -2.2% |
| 2021 | 36.75% | +49.9% |
| 2020 | 24.52% | -15.7% |
| 2019 | 29.07% | -12.1% |
| 2018 | 33.08% | +11.1% |
| 2017 | 29.79% | +9.6% |
| 2016 | 27.19% | - |